U.S. FDA approves Amgen heart failure drug

April 15 (Reuters) - U.S. health regulators on Wednesday approved Amgen Inc's Corlanor to treat patients with chronic heart failure, giving the world's largest biotechnology company its first cardiovascular medicine product.